SeaStar Medical Holding Corporation (ICU)

NASDAQ: ICU · Real-Time Price · USD
0.6552
+0.0464 (7.62%)
At close: Aug 1, 2025, 4:00 PM
0.6402
-0.0150 (-2.29%)
After-hours: Aug 1, 2025, 4:57 PM EDT
7.62%
Market Cap14.80M
Revenue (ttm)428,000
Net Income (ttm)-15.91M
Shares Out 22.59M
EPS (ttm)-3.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,343,614
Open0.6120
Previous Close0.6088
Day's Range0.5500 - 0.6552
52-Week Range0.3054 - 9.0870
Beta-1.07
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2025

About AZEK

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Employees 19
Stock Exchange NASDAQ
Ticker Symbol ICU
Full Company Profile

Financial Performance

Financial Statements

News

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DENVER, July 31, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

1 day ago - GlobeNewsWire

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveilla...

10 days ago - GlobeNewsWire

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Highest Rated Children's Medical Centers Now Employ QUELIMMUNE for  Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for  Future Analysis of QUELIMMUNE Performance...

16 days ago - GlobeNewsWire

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

22 days ago - GlobeNewsWire

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Nationally Recognized Texas Children's Hospital Adds First-In-Class Therapy as a Potential Life-Saving Treatment in Ultra-Rare Cases of Pediatric AKI Nationally Recognized Texas Children's Hospital Ad...

24 days ago - GlobeNewsWire

SeaStar Medical Announces Positive Nasdaq Listing Determination

DENVER, July 02, 2025 (GLOBE NEWSWIRE) -- Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ f...

4 weeks ago - GlobeNewsWire

SeaStar Medical Reports Update on Nasdaq Listing Status

DENVER, June 25, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing ...

5 weeks ago - GlobeNewsWire

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Cincinnati Children's Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE Therapy DENVER, June 24, 2025 (GLOBE NE...

5 weeks ago - GlobeNewsWire

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

$4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants $4 million upfront with up to an additional $4 million of ...

6 weeks ago - GlobeNewsWire

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a...

7 weeks ago - GlobeNewsWire

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

Coverage marks SeaStar Medical's second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a clinical trial

2 months ago - GlobeNewsWire

SeaStar Medical Holding Corporation (ICU) Q1 2025 Earnings Call Transcript

SeaStar Medical Holding Corporation (NASDAQ:ICU) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Jackie Cossmon - IR; WheelHouse Life Science Advisors Eric Schlorff - CE...

2 months ago - Seeking Alpha

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

DENVER, May 14, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing o...

2 months ago - GlobeNewsWire

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA Filing Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA Filing

2 months ago - GlobeNewsWire

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing ...

3 months ago - GlobeNewsWire

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin...

3 months ago - GlobeNewsWire

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin...

4 months ago - GlobeNewsWire

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin...

4 months ago - GlobeNewsWire

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

DENVER, March 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin...

4 months ago - GlobeNewsWire

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Company recognized for treatment recently approved in the U.S. for pediatric acute kidney injury (AKI) due to sepsis. NEW YORK , March 18, 2025 /PRNewswire/ -- SeaStar Medical (Nasdaq: ICU) has been s...

4 months ago - PRNewsWire

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its previously announced registered direct offering, priced...

6 months ago - GlobeNewsWire

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hy...

6 months ago - GlobeNewsWire

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Study to be conducted under $3.6 million NIH grant  DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing pr...

7 months ago - GlobeNewsWire

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hy...

7 months ago - GlobeNewsWire

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

DENVER, Dec. 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hy...

7 months ago - GlobeNewsWire